Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Bellevue share: investment from three years ago would have fallen by 64.63%

An investment of 10,000 CHF in Bellevue three years ago would be worth only 3,536.59 CHF at the current closing price of 6.96 CHF, representing a loss of 64.63%. The closing price at the time of purchase was 19.68 CHF, which would have resulted in 508.13 Bellevue shares. The most recent market capitalization is 92.91 million CHF; stock splits and dividends were not taken into account in the calculation. » More on finanzen.net
Bellevue Group reports half-year profit of CHF 1.8 million and cuts costs

Bellevue Group reports a group profit of CHF 1.8 million for H1 2026, operating income of CHF 26.2 million (+4.4%) and reduced operating expenses to CHF 23.8 million (-3.2%) thanks to initiated cost-cutting measures; expenses include one-off write-downs of CHF 0.6 million. Assets under management fell to CHF 4.8 billion (-8.7%), driven by negative performance in medtech/healthcare and net outflows of around CHF 490 million. Positive factors included the strong performance of BB Biotech (+14.1% share-price increase) and inflows of CHF 37 million into several strategies; Bellevue is positioning itself for an expected recovery in the healthcare sector and is focusing on distribution, technology and efficiency gains. » More on de.investing.com
Bellevue records 2025 profit decline due to healthcare sector and US dollar weakness

Asset manager Bellevue reports a sharp drop in profits for 2025. The cause was weakness in the healthcare sector and the depreciation of the US dollar, which weighed on results. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Bellevue has already paid €0.16 in dividends. The last payout was in March.

Financials

In the last quarter, Bellevue had revenue of €28.56m and net profit of €1.92m

(EUR)	June 2026	YoY
Revenue	28.56m	-
Gross profit	24.8m	-
Net profit	1.92m	-
EBITDA	4.55m	-

Fundamentals

Metric	Value
Market capitalization	€101.36m
Number of shares	13.4m
52-week high/low	€40.73 - €7.24
Dividend yield	2.18%
Dividends TTM	€0.16
Beta	0.87
P/E ratio	27.08
PEG ratio	0.32
P/B ratio	0.81
P/S ratio	1.74

Company profile

Die Bellevue Group AG erbringt Vermögensverwaltungsdienstleistungen in der Schweiz, in Grossbritannien, Deutschland und international. Das Unternehmen bietet eine Reihe von Produkten in den Bereichen spezialisierte Healthcare-Equity-, ausgewählte Nischen- und Unternehmerstrategien an. Darüber hinaus bietet das Unternehmen verschiedene Investmentfonds und Anlagelösungen für institutionelle, intermediäre und private Kunden sowie Anlageberatung und Research-Dienstleistungen an. Das Unternehmen wurde 1993 gegründet und hat seinen Hauptsitz in Küsnacht, Schweiz.